
Overview
Background
Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.
She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.
In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).
On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.
Research Interests
Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.
Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.
Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.
Christine’s current projects include:
- Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
- Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
- Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
- Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
- Improving gentamycin dosing in paediatric oncology patients
- Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
- Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
- Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis
Projects currently available for interested research higher degree students include:
- Dose optimisation of busulfan in paediatric bone marrow transplant recipients
- Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
- Examining Bayesian forecasting methods to predict immunosuppressant exposure
- Examining the international use of immunosuppressant and anti-rheumatic drugs
- Examining the influence of plasma exchange on immunosuppressant drug exposure
Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.
Teaching interests
Co-ordinates:
- PHRM3052- Biological Fate of Drugs
Teaches in:
- PHRM3052- Biological Fate of Drugs
- PHRM3011- Quality Use of Medicines
Availability
- Dr Christine Staatz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor, The University of Queensland
- Bachelor (Honours) of Pharmacy, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Christine Staatz’s works on UQ eSpace
2020
Conference Publication
Examining tacrolimus exposure in paediatric liver transplant recipients.
Yu Oi Sze Isy, Steward-Harrison, L. and Staatz, C. E. (2020). Examining tacrolimus exposure in paediatric liver transplant recipients.. World Conference of Paediatric Gastroenterology, Hepatology and Nutrition, Copenhagen, Denmark, June 2020.
2020
Conference Publication
The burden of venepuncture for kidney transplant patients and interest in possible solutions.
Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). The burden of venepuncture for kidney transplant patients and interest in possible solutions. . Society of Hospital Pharmacists of Australia, Online, 21-22 November 2020.
2020
Conference Publication
Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.
Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients. . RBWH Symposium, Brisbane, QLD Australia, 7-11 December 2020.
2020
Conference Publication
Pharmacokinetics of iIntravenous busulfan in children undergoing haematopoietic stem cell transplant and evidence for non-linear pharmacokinetic behavior
Lawson, R., Fraser, C., Staatz, C. E. and Hennig, S. (2020). Pharmacokinetics of iIntravenous busulfan in children undergoing haematopoietic stem cell transplant and evidence for non-linear pharmacokinetic behavior. Australian & New Zealand Children’s Haematology/Oncology Group Annual Scientific Meeting, Melbourne, VIC Australia, 11-13th June 2020.
2019
Journal Article
Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y
2019
Journal Article
Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687
2019
Journal Article
Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention
Metz, David K., Holford, Nick, Kausman, Joshua Y., Walker, Amanda, Cranswick, Noel, Staatz, Christine E., Barraclough, Katherine A. and Ierino, Francesco (2019). Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention. Transplantation, 103 (10), 2012-2030. doi: 10.1097/TP.0000000000002762
2019
Journal Article
Pharmacometrics in Australasia — twenty years of population approach group of Australia and New Zealand
Hennig, Stefanie, Hannam, Jacqueline A., Kirkpatrick, Carl M.J., Staatz, Christine E., Holford, Sam, Duffull, Stephen B., Al-Sallami, Hesham S., Charles, Bruce G., Holford, Nick and Foster, David J.R. (2019). Pharmacometrics in Australasia — twenty years of population approach group of Australia and New Zealand. CPT: Pharmacometrics and Systems Pharmacology, 8 (10), 701-704. doi: 10.1002/psp4.12460
2019
Journal Article
An evaluation of the user‐friendliness of Bayesian Forecasting programs in a clinical setting
Kumar, Alzana A., Burgard, Marc, Stacey, Sonya, Sandaradura, Indy, Lai, Tony, Coorey, Christine, Cincunegui, Marisol, Staatz, Christine E. and Hennig, Stefanie (2019). An evaluation of the user‐friendliness of Bayesian Forecasting programs in a clinical setting. British Journal of Clinical Pharmacology, 85 (10) bcp.14066, 2436-2441. doi: 10.1111/bcp.14066
2019
Journal Article
O11 Characterising the pharmacokinetics of phenobarbitone in neonates to facilitate future individualised dosing
Williams, A, Donovan, T, Charles, B and Staatz, C (2019). O11 Characterising the pharmacokinetics of phenobarbitone in neonates to facilitate future individualised dosing. Archives of Disease in Childhood, 104 (6). doi: 10.1136/archdischild-2019-esdppp.11
2019
Journal Article
Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients
Cossart, Amelia R., Cottrell, W. Neil, Campbell, Scott B., Isbel, Nicole M. and Staatz, Christine E. (2019). Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients. Translational Andrology and Urology, 8 (S2), S198-S213. doi: 10.21037/tau.2018.10.16
2019
Journal Article
Quizzing for success: evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses
Hennig, Stefanie, Staatz, Christine E., Bond, Jacqueline A., Leung, Debbie and Singleton, Judith (2019). Quizzing for success: evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses. Currents in Pharmacy Teaching and Learning, 11 (7), 742-749. doi: 10.1016/j.cptl.2019.03.014
2019
Conference Publication
Saliva prednisolone measurements in adult kidney transplant recipients
Staatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019.
2019
Conference Publication
A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing
Williams, A., Donovan, T., Charles, B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. Population Approach Group Australia and New Zealand, Adelaide, SA, Australia, February 2019.
2019
Journal Article
Investigating barriers to immunosuppressant medication adherence in renal transplant patients
Cossart, Amelia R., Staatz, Christine E., Campbell, Scott B., Isbel, Nicole M. and Cottrell, W. Neil (2019). Investigating barriers to immunosuppressant medication adherence in renal transplant patients. Nephrology, 24 (1), 102-110. doi: 10.1111/nep.13214
2019
Conference Publication
Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.
Stanley, K., Gardiner, K., Schultz, K. and Staatz, C. E. (2019). Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.. Australian Pharmaceutical Sciences Association, Melbourne, Australia, December 2019.
2019
Conference Publication
A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing
Williams, A., Donovan, T., Charles B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. European Society of Developmental, Perinatal and Paediatric Pharmacology Conference, Basel, Switzerland, 28-30 May 2019.
2019
Conference Publication
Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients
Cossart, A., Cottrell, N., Mcstea, M., Isbel, N., Campbell, S. and Staatz, C. E. (2019). Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Queenstown, New Zealand, November 2019.
2018
Journal Article
Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8
2018
Journal Article
Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit
Adewumi, Adeleke D., Staatz, Christine E., Hollingworth, Samantha A., Connor, Jason P. and Alati, Rosa (2018). Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit. Drug Safety, 41 (11), 1-11. doi: 10.1007/s40264-018-0687-6
Funding
Current funding
Supervision
Availability
- Dr Christine Staatz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
To investigate the pharmacotherapy management of the bariatric surgery patient and the impact of the pharmacist in the multidisciplinary team
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
Exploring free plasma tacrolimus and mycophenolic acid measurements and defining a therapeutic target range for therapeutic drug monitoring
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
Doctor Philosophy
The IMPEDE-PKD Clinical Trial - Investigating the repurposing of metformin in ADPKD
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Dr Andrew Mallett, Associate Professor Andrea Viecelli
-
Doctor Philosophy
Establishing the Role of Metformin for Autosomal Dominant Polycystic Kidney Disease Management
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Associate Professor Andrea Viecelli, Dr Andrew Mallett
Completed supervision
-
2024
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
2023
Doctor Philosophy
Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Children: Once daily administration
Principal Advisor
-
2022
Doctor Philosophy
Optimising immunosuppressant medicines in elderly kidney transplant recipients
Principal Advisor
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Optimizing beta-lactam antibiotic dosing in critically ill patients: Prolonged infusion versus intermittent bolus administration
Associate Advisor
Other advisors: Professor Jeffrey Lipman, Professor Jason Roberts
-
2012
Doctor Philosophy
Pharmacokinetic, Pharmacogenetic and Pharmacodynamic Monitoring of Immunosuppressive Therapy in Adult Kidney Transplant Recipients
Associate Advisor
-
2018
Doctor Philosophy
Optimising gentamicin therapy in paediatric oncology patients
Joint Principal Advisor
-
2017
Doctor Philosophy
The impact of increasing patient weight on the dosing of high-dose methotrexate chemotherapy in aggressive non-Hodgkin lymphoma
Joint Principal Advisor
Media
Enquiries
For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team: